Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry;Ruhepuls und Funktionelle Einschränkungen als Prognostische Parameter bei Herzinsuffizienten Patienten im Tatsächlichen Leben. Daten aus dem Herzinsuffizienz-Register der ÖKG?

Wiener Klinische Wochenschrift

Volumn 123, Issue 11-12, 2011, Pages 378-383

  Fruhwald, Friedrich M ^a   Ulmer, Hanno ^b   Pacher, Richard ^a   Pölzl, Gerhard ^a   Dornaus, Claudia ^c   Wieser, Manfred ^d   Ebner, Christian ^e   Reiter, Susanne ^f   Kaltenbach, Lalit ^b   Altenberger, Johann ^g  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c HANUSCH HOSPITAL   (Austria)

^d Krankenhaus Krems   (Austria)

^e ELISABETHINEN HOSPITAL   (Austria)

^f Abteilung fur Innere Medizin   (Austria)

^g UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Heart failure; heart rate; prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; AUSTRIA; CARDIOVASCULAR RISK; DISEASE CLASSIFICATION; FOLLOW UP; FUNCTIONAL DISEASE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PROGNOSIS; REGISTER; SINUS RHYTHM; SMOKING;

CAUSE OF DEATH; COHORT STUDIES; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RISK FACTORS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79960092849     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-1591-6     Document Type: Article

References (18)

1. K Dickstein A Cohen-Solal G Filippatos, et al. 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 933 989 18826876 10.1016/j.ejheart.2008.08.005
2. K Fox I Ford G Steg M Tendera M Robertson R Ferrari on behalf of the BEAUTIFUL investigators 2008 Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 817 821 18757091 10.1016/S0140-6736(08)61171-X
3. K Swedberg M Komajda M Böhm, et al. 2010 Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 875 885 20801500 10.1016/S0140-6736(10)61198-1 1:CAS:528:DC%2BC3cXhtFCltrzO
4. M Böhm K Swedberg M Komajda, et al. 2010 Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 367 886 894 10.1016/S0140-6736(10)61259-7
5. G Pölzl R Pacher H Altenberg, et al. 2010 Herzinsuffizienz-Register- (HIR) Austria 2006-2009: Erfahrungen und Konsequenzen J Kardiol 17 85 92
6. JGF Cleland K Swedberg F Follath, et al. 2003 The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur Heart J 24 442 463 12633546 10.1016/S0195-668X(02)00823-0 1:STN:280:DC%2BD3s7itVWjug%3D%3D (Pubitemid 36286187)
7. M Komajda F Follath K Swedberg, et al. 2003 The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment Eur Heart J 24 464 471 12633547 10.1016/S0195- 668X(02)00700-5 1:STN:280:DC%2BD3s7itVWjuw%3D%3D (Pubitemid 36286188)
8. A Maggioni U Dahlström G Filippatos, et al. 2010 EURObservational research programme: the heart failure pilot survey (ESC-HF pilot) Eur J Heart Fail 12 1076 1084 20805094 10.1093/eurjhf/hfq154
9. K Dickstein N Bogale S Priori, et al. 2009 The European cardiac resynchronization therapy survey Eur Heart J 30 2450 2460 19723694 10.1093/eurheartj/ehp359
10. GC Fonarow JT Heywood PA Heidenreich M Lopatin CW Yancy ADHERE Scientific Advisory Committee and Investigators 2007 Temporal trends in clinical characteristics, treatments, and outcomes in heart failure hospitaliziations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 153 1021 1028 17540205 10.1016/j.ahj.2007.03.012 (Pubitemid 46809844)
11. S Stewart K MacIntyre DJ Hole S Capewell JJV McMurray 2001 More malignant than cancer? Five-year survival following a first admission for heart failure Eur J Heart Fail 3 315 322 11378002 10.1016/S1388-9842(00)00141-0 1:STN:280:DC%2BD3M3psleruw%3D%3D (Pubitemid 32895839)
12. F Zannad S Briancon Y Juilliere, et al. 1999 Incidence, clinical and etiologic features and outcomes in advanced chronic heart failure: the EPICAL study J Am Coll Cardiol 33 734 742 10080475 10.1016/S0735-1097(98)00634-2 1:STN:280:DyaK1M7nvVGlsg%3D%3D
13. M Komajda P Lapuerta N Hermans, et al. 2005 Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey Eur Heart J 26 1653 1659 15827061 10.1093/eurheartj/ehi251 (Pubitemid 41389697)
14. B Pitt F Zannad WJ Remme, et al. 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 709 717 10471456 10.1056/NEJM199909023411001 1:CAS:528:DyaK1MXmtVyrurk%3D (Pubitemid 29407370)
15. B Pitt W Remme F Zannad, et al. 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 1309 1321 12668699 10.1056/NEJMoa030207 1:CAS:528:DC%2BD3sXis1ehurY%3D (Pubitemid 36384098)
16. MR Bristow LA Saxon J Boehmer, et al. 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140 2150 15152059 10.1056/NEJMoa032423 1:CAS:528:DC%2BD2cXktF2isrc%3D (Pubitemid 38637994)
17. JGF Cleland JC Dauber E Erdmann, et al. 2005 The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 1539 1549 15753115 10.1056/NEJMoa050496 1:CAS:528:DC%2BD2MXjtFGnsLo%3D (Pubitemid 40517094)
18. AJ Moss WJ Hall DS Cannom, et al. 2009 Cardiac-resynchronsation therapy for the prevention of heart-failure events N Engl J Med 361 1329 1338 19723701 10.1056/NEJMoa0906431